Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

16 trials with published results (19%)

Research Maturity

53 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

9.6%

8 terminated out of 83 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

18%

15 trials in Phase 3/4

Results Transparency

30%

16 of 53 completed with results

Key Signals

16 with results87% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (16)
P 1 (5)
P 2 (18)
P 3 (5)
P 4 (10)

Trial Status

Completed53
Unknown12
Terminated8
Withdrawn4
Recruiting4
Active Not Recruiting1

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 53 completed trials

Clinical Trials (83)

Showing 20 of 20 trials
NCT07028112RecruitingPrimary

Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

NCT05294471Recruiting

Fully Automated High-Throughput Quantitative MRI of the Liver

NCT02164253Phase 2Completed

Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients

NCT07352878Not Yet Recruiting

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

NCT02025543CompletedPrimary

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

NCT04198545Active Not Recruiting

Ethnic Differences in Iron Absorption (FeGenes)

NCT04423237CompletedPrimary

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

NCT05355766Phase 2Completed

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

NCT05326503Not ApplicableCompleted

Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia

NCT06146608Recruiting

Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption

NCT04741542Phase 1TerminatedPrimary

Safety of SP-420 in the Treatment of Transfusional Iron Overload

NCT06596746Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

NCT04631718Completed

MRI QSM Imaging for Iron Overload

NCT03591575Phase 4Completed

Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children

NCT02443545Phase 4TerminatedPrimary

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

NCT04614779Phase 2Completed

Long-term Clinical Study of CN128 in Thalassemia Patients

NCT06137079UnknownPrimary

"Iron Overload and Endocrinological Diseases"

NCT01376622CompletedPrimary

Changes in Pituitary Iron and Volume With Deferasirox

NCT00401336Not ApplicableCompletedPrimary

Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging

NCT01045525Phase 3Completed

Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis

Scroll to load more

Research Network

Activity Timeline